| scholarly article | Q13442814 |
| P50 | author | Jerald P Radich | Q88465518 |
| Brent L Wood | Q89862846 | ||
| Harry P Erba | Q93114769 | ||
| Cheryl L. Willman | Q110811050 | ||
| Derek L Stirewalt | Q114442005 | ||
| Era L Pogosova-Agadjanyan | Q114777555 | ||
| Galina L Pogosov | Q114777558 | ||
| Alan F List | Q63634762 | ||
| John Godwin | Q73851740 | ||
| Frederick R. Appelbaum | Q75025725 | ||
| Thomas R Chauncey | Q75025754 | ||
| Megan Othus | Q75025967 | ||
| Soheil Meshinchi | Q87838719 | ||
| P2093 | author name string | Kenneth J Kopecky | |
| Min Fang | |||
| I-Ming L Chen | |||
| Anna Moseley | |||
| P2860 | cites work | Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study | Q24643738 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). | Q27824861 | ||
| The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia | Q27851416 | ||
| Prognostic relevance of integrated genetic profiling in acute myeloid leukemia | Q27851726 | ||
| Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG). | Q27852247 | ||
| Accuracy of Molecular Data Generated with FFPE Biospecimens: Lessons from the Literature | Q28084521 | ||
| Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function | Q30432896 | ||
| National Cancer Institute Biospecimen Evidence-Based Practices: a novel approach to pre-analytical standardization | Q30576732 | ||
| "Proof of concept" pilot study: bioprocess chain of custody and bioresource sample management temperature observations. Sample level temperature trends and stability data obtained via utilization of bluechiip(®) temperature tracking technology | Q30824860 | ||
| Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia | Q31774863 | ||
| A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031). | Q33502338 | ||
| RNA-seq: impact of RNA degradation on transcript quantification | Q33808041 | ||
| Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis | Q34523534 | ||
| Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease | Q34524219 | ||
| Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study | Q34528336 | ||
| Sample processing obscures cancer-specific alterations in leukemic transcriptomes. | Q34601323 | ||
| The prognostic significance of IRF8 transcripts in adult patients with acute myeloid leukemia | Q34962889 | ||
| Biospecimen Reporting for Improved Study Quality | Q35125775 | ||
| Prognostic significance of NPM1 mutations in the absence of FLT3-internal tandem duplication in older patients with acute myeloid leukemia: a SWOG and UK National Cancer Research Institute/Medical Research Council report | Q35215042 | ||
| Expression of the potential therapeutic target CXXC5 in primary acute myeloid leukemia cells - high expression is associated with adverse prognosis as well as altered intracellular signaling and transcriptional regulation | Q35550103 | ||
| Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report | Q35687895 | ||
| Downregulation of the Wnt inhibitor CXXC5 predicts a better prognosis in acute myeloid leukemia | Q35724527 | ||
| Clinical implications of FLT3 mutations in pediatric AML. | Q35848876 | ||
| Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction | Q35848938 | ||
| Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia | Q35849643 | ||
| Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia | Q36457184 | ||
| High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group | Q37125803 | ||
| Epigenetics meets genetics in acute myeloid leukemia: clinical impact of a novel seven-gene score | Q37570427 | ||
| Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel | Q37624593 | ||
| DNA fingerprinting: a quality control case study for human biospecimen authentication | Q37716180 | ||
| Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group | Q38063697 | ||
| Generating a comprehensive set of standard operating procedures for a biorepository network-The CTRNet experience. | Q38212322 | ||
| Certification for biobanks: the program developed by the Canadian Tumour Repository Network (CTRNet). | Q38213171 | ||
| Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). | Q38213611 | ||
| Storage of human biospecimens: selection of the optimal storage temperature. | Q38219478 | ||
| A practical approach to clinical and research biobanking | Q38228507 | ||
| A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen? | Q38263937 | ||
| Gene-expression profiling identifies distinct subclasses of core binding factor acute myeloid leukemia | Q38301992 | ||
| TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns | Q38428907 | ||
| Preanalytical variables affecting the integrity of human biospecimens in biobanking | Q38484066 | ||
| Quality assessment and preservation of RNA from biobank tissue specimens: a systematic review. | Q38645035 | ||
| Hematopoietic stem cell transplantation for patients with AML in first complete remission | Q38667488 | ||
| Emerging therapeutic drugs for AML. | Q38667491 | ||
| Freezing effects on the acute myeloid leukemia cell proteome and phosphoproteome revealed using optimal quantitative workflows | Q38876979 | ||
| Identification of genes with abnormal expression changes in acute myeloid leukemia | Q40168272 | ||
| Prognostic methylation markers for overall survival in cytogenetically normal patients with acute myeloid leukemia treated on SWOG trials | Q40325678 | ||
| A 10-minute prototype assay for tissue degradation monitoring in clinical specimens | Q40880104 | ||
| Viable mononuclear cell stability study for implementation in a proficiency testing program: impact of shipment conditions | Q42409561 | ||
| Utility of peripheral blood for cytogenetic and mutation analysis in myelodysplastic syndrome. | Q43463368 | ||
| Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study | Q43806484 | ||
| Prognostic importance of histone methyltransferase MLL5 expression in acute myeloid leukemia | Q45306545 | ||
| Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group | Q46192276 | ||
| Individual-specific variation of gene expression in peripheral blood leukocytes. | Q47395767 | ||
| NCCN Clinical Practice Guidelines Acute myeloid leukemia | Q47565627 | ||
| A comprehensive assessment of immunophenotyping performed in cryopreserved peripheral whole blood | Q48318227 | ||
| Assessment of distribution of CD34 epitope classes in fresh and cryopreserved peripheral blood progenitor cells and acute myeloid leukemic blasts. | Q50757071 | ||
| FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia. | Q54008419 | ||
| Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases. | Q54162472 | ||
| NCCN Work Group Report: Emerging Issues in Tissue Allocation | Q56766449 | ||
| Expression of immunological markers on leukemic cells before and after cryopreservation and thawing | Q57115555 | ||
| Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia | Q57415017 | ||
| High Expression Levels of theETS-Related Gene,ERG, Predict Adverse Outcome and Improve Molecular Risk-Based Classification of Cytogenetically Normal Acute Myeloid Leukemia: A Cancer and Leukemia Group B Study | Q59315411 | ||
| The cryopreservation of leukaemia cells: morphological and functional changes | Q66855488 | ||
| Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA) | Q78290356 | ||
| Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500) | Q80791117 | ||
| Ensuring quality in studies linking cancer registries and biobanks | Q82442383 | ||
| Validation of a modified cryopreservation method for leukemic blasts for flow cytometry assessment | Q82458838 | ||
| Risk stratification of intermediate-risk acute myeloid leukemia: integrative analysis of a multitude of gene mutation and gene expression markers | Q84150307 | ||
| Molecular analysis of a collection of clinical specimens stored at 4 degrees C as an alternative to snap-freezing | Q84174832 | ||
| P921 | main subject | acute myeloid leukemia | Q264118 |
| biomarker | Q864574 | ||
| P577 | publication date | 2017-11-27 | |
| P1433 | published in | Biopreservation and Biobanking | Q27723562 |
| P1476 | title | Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report |
| Q98576962 | AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report | cites work | P2860 |
Search more.